Trabalho de Conclusão de Curso - Graduação

Síndrome metabólica como fator prognóstico em pacientes clínicos internados em um hospital universitário da região norte do país

Introduction: Metabolic syndrome (MS) can be defined as a set of cardiovascular risk factors related to central obesity and insulin resistance, which can influence the prognosis of hospitalized patients. Objectives: To identify the prevalence of MS among patients admitted to the med...

ver descrição completa

Autor principal: AIRES, César Augusto Martins
Outros Autores: OHUSCHI, Gabriel Greco
Grau: Trabalho de Conclusão de Curso - Graduação
Publicado em: 2023
Assuntos:
Acesso em linha: https://bdm.ufpa.br:8443/jspui/handle/prefix/5614
Resumo:
Introduction: Metabolic syndrome (MS) can be defined as a set of cardiovascular risk factors related to central obesity and insulin resistance, which can influence the prognosis of hospitalized patients. Objectives: To identify the prevalence of MS among patients admitted to the medical clinic ward, in a university hospital, as well as to correlate this syndrome with the prognosis of these patients. Methods: An observational cohort study was conducted, whose data were obtained through physical examination and by reviewing the medical records of each patient. Thus, analyzes of demographic and clinical variables, physical examination and complementary exams were performed. For the assessment of MS, the concept of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP­-ATP III) was used. Results: Eighty consecutive patients admitted to the medical clinic ward of Hospital Universitário João de Barros Barreto (HUJBB) were selected for a period of 4 months. It was observed that 55% of the patients did not have MS criteria (Group 1 – G1) and 45% had the syndrome (Group 2 – G2). G2 had a mean age of more than a decade (57.4 ±16.1 x 47 ±19.9, p= 0.014) and a higher prevalence of women (53.3% x 47.5%, p. >0.05). Within this same group, DM, SAH and obesity were the most prevalent factors (94.4%; 72.2% and 61%). Regarding the days of hospitalization, averages of 24.8 days and 25.7 days were observed for groups 1 and 2, respectively (p= 0.835). As for the evolutionary characteristics, there was a similarity between the groups regarding the number of deaths (11.4% x 11.1%, p= 1) and a superiority in the values regarding the transfer to intensive care in G2 (4.5% x 11 .1%), despite not reaching statistical significance (p= 0.401). There was a higher incidence of echocardiographic changes in patients with MS (84%) than in patients without MS (60%). Conclusion: Almost half of the entire population studied had MS, with the highest prevalence in women and patients over 60 years of age. Diabetes mellitus, arterial hypertension and obesity were the component factors with the highest prevalence in G2. It was seen that MS did not affect the length of stay and the prognosis of the patients analyzed, as there was no significant distinction between the groups in these variables. However, MS may have been a triggering or influencing factor in the cause of such hospitalizations.